
A Covid-19 vaccine developed by Valneva has been given regulatory approval by the Medicines and Healthcare products Regulatory Agency (MHRA).
The UK had been due to receive 100 million doses of the French firm’s jab, but the Government cancelled the deal in September due to a “breach of obligations”.